Difference between revisions of "Serous carcinoma of the ovary"

Jump to navigation Jump to search
(10 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{ Infobox diagnosis
{{ Infobox diagnosis
| Name      = {{PAGENAME}}
| Name      = {{PAGENAME}}
| Image      =  
| Image      = Serous carcinoma - omentum 3 -- very high mag.jpg
| Width      =
| Width      =
| Caption    =  
| Caption    = Serous carcinoma. [[H&E stain]].
| Synonyms  =
| Synonyms  =
| Micro      =
| Micro      =
Line 11: Line 11:
| IHC        = WT-1 +ve, CK7 +ve, ER +ve, HNF-1beta -ve
| IHC        = WT-1 +ve, CK7 +ve, ER +ve, HNF-1beta -ve
| EM        =
| EM        =
| Molecular  =
| Molecular  = +/-BRCA1 mutation, +/-BRCA2 mutation
| IF        =
| IF        =
| Gross      = solid and cystic, serous fluid
| Gross      = solid and cystic, serous fluid
Line 35: Line 35:
*Most common malignant ovarian tumour in the eldery.
*Most common malignant ovarian tumour in the eldery.
*Poor prognosis.
*Poor prognosis.
*May be associated with a ''BRCA1 gene'' or ''BRACA2 gene'' mutation.<ref name=pmid23707676>{{Cite journal  | last1 = Demsky | first1 = R. | last2 = McCuaig | first2 = J. | last3 = Maganti | first3 = M. | last4 = Murphy | first4 = KJ. | last5 = Rosen | first5 = B. | last6 = Armel | first6 = SR. | title = Keeping it simple: genetics referrals for all invasive serous ovarian cancers. | journal = Gynecol Oncol | volume = 130 | issue = 2 | pages = 329-33 | month = Aug | year = 2013 | doi = 10.1016/j.ygyno.2013.05.003 | PMID = 23707676 }}</ref>
*May be associated with a ''[[BRCA1]] gene'' or ''[[BRCA2]] gene'' mutation.<ref name=pmid23707676>{{Cite journal  | last1 = Demsky | first1 = R. | last2 = McCuaig | first2 = J. | last3 = Maganti | first3 = M. | last4 = Murphy | first4 = KJ. | last5 = Rosen | first5 = B. | last6 = Armel | first6 = SR. | title = Keeping it simple: genetics referrals for all invasive serous ovarian cancers. | journal = Gynecol Oncol | volume = 130 | issue = 2 | pages = 329-33 | month = Aug | year = 2013 | doi = 10.1016/j.ygyno.2013.05.003 | PMID = 23707676 }}</ref>
**Approximately 20% of high-grade serous carcinoma are associated with BRCA1 or BRCA2.<ref name=pmid22776961>{{Cite journal  | last1 = Schrader | first1 = KA. | last2 = Hurlburt | first2 = J. | last3 = Kalloger | first3 = SE. | last4 = Hansford | first4 = S. | last5 = Young | first5 = S. | last6 = Huntsman | first6 = DG. | last7 = Gilks | first7 = CB. | last8 = McAlpine | first8 = JN. | title = Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy. | journal = Obstet Gynecol | volume = 120 | issue = 2 Pt 1 | pages = 235-40 | month = Aug | year = 2012 | doi = 10.1097/AOG.0b013e31825f3576 | PMID = 22776961 }}</ref>  


Precursors lesions:
Precursors lesions:
*[[Serous borderline tumour]]s for low-grade serious carcinoma.
*[[Serous borderline tumour]]s for low-grade serious carcinoma.
**Generally do not progress to high-grade serous carcinoma.{{fact}}
*[[Serous tubal intraepithelial carcinoma]] (STIC)<ref name=pmid23240669>{{Cite journal  | last1 = Vang | first1 = R. | last2 = Shih | first2 = IeM. | last3 = Kurman | first3 = RJ. | title = Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. | journal = Histopathology | volume = 62 | issue = 1 | pages = 44-58 | month = Jan | year = 2013 | doi = 10.1111/his.12046 | PMID = 23240669 }}</ref> for high-grade serous carcinoma.
*[[Serous tubal intraepithelial carcinoma]] (STIC)<ref name=pmid23240669>{{Cite journal  | last1 = Vang | first1 = R. | last2 = Shih | first2 = IeM. | last3 = Kurman | first3 = RJ. | title = Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. | journal = Histopathology | volume = 62 | issue = 1 | pages = 44-58 | month = Jan | year = 2013 | doi = 10.1111/his.12046 | PMID = 23240669 }}</ref> for high-grade serous carcinoma.


Line 93: Line 95:


===Images===
===Images===
<gallery>
Image: Serous carcinoma - omentum -- high mag.jpg | Serous ca - high mag.
Image: Serous carcinoma - omentum -- very high mag.jpg | Serous ca - very high mag.
Image: Serous carcinoma - omentum 3 -- very high mag.jpg | Serous ca - very high mag.
</gallery>
<gallery>
<gallery>
Image:Serous_carcinoma_cytology.jpg | Serous carcinoma - cytology. (WC)
Image:Serous_carcinoma_cytology.jpg | Serous carcinoma - cytology. (WC)
Line 100: Line 107:


==IHC==
==IHC==
*WT-1 +ve - '''key immunostain'''.<ref name=pmid18830127>{{Cite journal  | last1 = Köbel | first1 = M. | last2 = Kalloger | first2 = SE. | last3 = Carrick | first3 = J. | last4 = Huntsman | first4 = D. | last5 = Asad | first5 = H. | last6 = Oliva | first6 = E. | last7 = Ewanowich | first7 = CA. | last8 = Soslow | first8 = RA. | last9 = Gilks | first9 = CB. | title = A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. | journal = Am J Surg Pathol | volume = 33 | issue = 1 | pages = 14-21 | month = Jan | year = 2009 | doi = 10.1097/PAS.0b013e3181788546 | PMID = 18830127 }}</ref>
*[[WT-1]] +ve - '''key immunostain'''.<ref name=pmid18830127>{{Cite journal  | last1 = Köbel | first1 = M. | last2 = Kalloger | first2 = SE. | last3 = Carrick | first3 = J. | last4 = Huntsman | first4 = D. | last5 = Asad | first5 = H. | last6 = Oliva | first6 = E. | last7 = Ewanowich | first7 = CA. | last8 = Soslow | first8 = RA. | last9 = Gilks | first9 = CB. | title = A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. | journal = Am J Surg Pathol | volume = 33 | issue = 1 | pages = 14-21 | month = Jan | year = 2009 | doi = 10.1097/PAS.0b013e3181788546 | PMID = 18830127 }}</ref>
*CK7 +ve.
*[[CK7]] +ve.
*CA-125 +ve.
*CA-125 +ve.
*ER +ve.<ref name=pmid21164285>{{Cite journal  | last1 = DeLair | first1 = D. | last2 = Oliva | first2 = E. | last3 = Köbel | first3 = M. | last4 = Macias | first4 = A. | last5 = Gilks | first5 = CB. | last6 = Soslow | first6 = RA. | title = Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. | journal = Am J Surg Pathol | volume = 35 | issue = 1 | pages = 36-44 | month = Jan | year = 2011 | doi = 10.1097/PAS.0b013e3181ff400e | PMID = 21164285 }}</ref>  
*ER +ve.<ref name=pmid21164285>{{Cite journal  | last1 = DeLair | first1 = D. | last2 = Oliva | first2 = E. | last3 = Köbel | first3 = M. | last4 = Macias | first4 = A. | last5 = Gilks | first5 = CB. | last6 = Soslow | first6 = RA. | title = Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. | journal = Am J Surg Pathol | volume = 35 | issue = 1 | pages = 36-44 | month = Jan | year = 2011 | doi = 10.1097/PAS.0b013e3181ff400e | PMID = 21164285 }}</ref>  
Line 137: Line 144:
Clinical and radiologic correlation is suggested for the determination of  
Clinical and radiologic correlation is suggested for the determination of  
the primary site of this serous carcinoma.
the primary site of this serous carcinoma.
High-grade serous carcinoma of ovary/fallopian tube/periteonum is associated
with BRCA1/2 mutation in approximately 20% of patients. Referral to genetic
counseling is recommended.
</pre>
</pre>


48,436

edits

Navigation menu